Novel biomarker found in ovarian cancer patients can predict response to therapy

Researchers have identified an independent prognostic factor, cancer/testis antigen 45, that is associated with extended disease-free survival for women with advanced ovarian cancer. Patients with high levels of CT45 in their tumors lived more than seven times as long as patients who lacked sufficient CT45. (Mehr in: Cancer News — ScienceDaily)